03-18 Metab Liver Dz Flashcards
• Discuss the clinical presentation including laboratory testing, and pathogenesis of the following conditions: Alpha 1 Antitrypsin Deficiency, Hereditary Hemochromatosis and Wilson's disease • Discuss the management of the above conditions • Describe glycogen storage diseases and their effect on the liver and selected other less common metabolic inherited liver diseases
OBJECTIVE: Clinical Presentation w/ labs of A1AT Deficiency; Acquired or Inherited?
Inherited, A.D. w/ co-dom expression (as common as CF; ~1% of COPD pts)
—only 10-15% of ZZ allelic individuals present w/ clinical dz
CLINICAL PRESENTATION: CHILD ≠ ADULT
Children: Liver > Lung
most common pedi liver dz
—Neonatal jaundice, hepatomegaly, failure to thrive, or acute liver failure
Adults: Lung > Liver
- Emphysema/COPE
- ZZ: 8X risk of cirrhosis, 20X risk of HCC
- SZ/MZ: heterozygotes w/ cirrhosis usually have another co-founding risk factor
- Lesson common:
- Necrotizing panniculitis- painful localized necrosis of subQ fat
- Anti-proteinase-3-positive vasculitis (painful bruising w/ serosanguinous weeping) [seen here]
LAB FINDINGS
- Low A1AT
- Protein geno- or phenotyping: MZ, SZ or ZZ A1AT alleles
- Consider bx to r/o other causes
CHILDREN: 25% w/ ↑ liver enzymes
OBJECTIVE: Pathogenesis of A1AT deficiency
A1AT Inhibits proteases, specifically neutrophil elastase released during inflammation
- 2 main organs involved w/ 2 very different Mechs
- Lung: Inability to inhibit neutrophil elastase leads to destruction of lung parenchyma → lung disease and COPD
- A1AT is responsible >90% of anti-elastase activity in alveolar lavage fluid
- Liver: Accumulation of aberrant folded A1AT protein in ER → apoptosis, mitochondrial injury, hepatic necrosis leading to fibrosis and cirrhosis
OBJECTIVE: Management of A1AT deficiency.
LIVER TX
- stop smoking (it makes liver dz worse, too)
- correct modifiable risk factors: wt, DM, HTN, etc.
- Liver transplant, PRN
- Experimental:
- Gene therapy
- Carbamezapine and Rifamycin
LUNG TX
- replace the A1AT w/ a functioning version to stop destruction of lung tissue by elastase
A1AT deficiency relatives
Other serine protease inhibitors
- C1 Inhibitor (hereditary angioedema)
- Antithrombin III (thrombosis)
- α1-antichymotrypsin (COPD)
Can be inherited with A1AT b/c close proximity on Chromosome 14
What are the 3 iron-regulating compounds? What are their fxns?
Hepcidin (hepatic bactericidal protein)
- Hormone produced in the liver that responds to serum iron levels
- Stimulates iron transportation into cells (M0s, enterocytes, hepatocytes)
- Binds ferroportin (iron exporter on M0s and basolateral enterocyte), internalizes it and targets it for degradation
- Acute phase reactant: ↑ in inflamm
Ferroportin
- Main iron export protein
- Found on enterocytes, hepatocytes, M0s
- Regulated by hepcidin binding
HFE protein
- HFE = Human hemochromatosis protein
- encoded by HFE gene
- Iron sensor found on hepatocytes
OBJECTIVE: Clinical presentation w/ labs of Hereditary Hemochromatosis; Acquired or Inherited?
CLINICAL PRESENTATION
- ♂ : ♀ = 8 : 1; Avg onset 40-50 y/o
- Most common s/sx:
- weakness, lethargy, arthralgias, abdominal pain, and ↓ libido or potency in ♂
- Exam:
- hepatosplenomegaly
- ascites, edema, and jaundice, may be present.
- Bronzed or slate-gray skin (Fe in basal epidermis)
- Other
- hypothyroid
- hypogonadotrophic hypogonadism
- cardiomyopathy, valvulopathy
- Arthropathy of 2nd/3rd MCPs w/ joint space narrowing, chondrocalcinosis, subchondral cyst formation, osteopenia, and swollen joints
- Infections in iron-loaded patients (Vibrio vulnificus, Listeria **monocytogenes, Yersinia enterocolitica, and Yersinia pseudotuberculosis)
LABS
- ↑ liver enzymes
- ↑ transferrin
- ↑ tranferrin sat
- ↑ iron index = age-adjusted serum Fe
- HFE genotype
- bad one = C282Y
- more minor = H63D
- (others S65C)
OBJECTIVE: Pathogenesis of Hereditary Hemochromatosis
- Mutation of hepatic Fe-sensor proteins (e.g. HFE)
- Hepatocytes “see” low iron → therefore they stop hepcidin synth
- ferroportin goes regulating pumping iron absorbed by enterocytes into the blood and allow its uptake by M0s, etc.
- Increased iron levels & transferrin saturation
- Deposition in the liver, heart, spleen and endocrine organs
OBJECTIVE: Management of Hereditary Hemochromatosis + Prognosis
- Routine phlebotomy
- If can’t tolerate: Rx = deferoxamine (iron-chelator)
- avoid Fe-rich food, Vit C (↑ absorption)
- avoid raw shellfish (vibrio risk)
Normal life span if tx’d before cirrhosis
- Arthritis, liver fibrosis, risk of HCC and hypogonadism do not improve, however
- Prognosis depends on genotype homozygous C282Y is the bad one RR of developing HCC = 120
OBJECTIVE: Clinical presentation w/ labs of Wilson’s disease
Kids - hepatic presentation
- Sx: fatigue, anorexia, or abdominal pain.
- High LFTs, hepatomegaly, fatty liver on bx
- Kayser-Fleischer rings (on slit lamp exam) [seen here]
Adults - neuro presentation
- movement: Tremors, ↓ coordination, + lose fine motor control
- rigid dystonia: Mask-like facies, rigidity, and gait disturbance + pseudobulbar (drool/dysarth) involvement
20% Have Pure Psychiatric Presentation
- Depression is common
- Phobias or compulsive behavior
- Aggressive or antisocial behavior
LAB FINDINGS
- ↑ 24hr urine Cu
- ↑ serum Cu
- ↓ ceruloplasmin
OBJECTIVE: Pathogenesis of Wilson’s disease
A.R. inherited disease of defective biliary Cu excretion protein ATP7B
- cannot excrete Cu into bile normally
- Cu builds up and accumulates in
- brain
- liver
- eyes
- heart
- kidneys
OBJECTIVE: Management of Wilson’s disease
Dietary
- eliminate copper-rich food such as organ meats, shellfish, nuts, chocolate, and mushrooms
- Analyze drinking water
Rx
- D- penicillamine = gold std
- Trientine - for neuro sx
- Zinc (maintenancy therapy)
- Liver transplant
- Genetic screening for family members
DDx for Kayser Fleischer Rings
Kayser-Fleischer rings are not specific for Wilson disease.
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
- Autoimmune Hepatitis
- or familial cholestatic syndromes.
OBJECTIVE: Describe glycogen storage diseases and their effect on the liver
Three types of glycogen storag disease
- GSD I = deficiency of glucose-6-phosphatase
- GSD III = amylo-1,6-glucosidase debranching enzyme
- GSD IV = Deficiency of the branching enzyme
Dx these w/ enzyme test on fresh liver tissue
Present w/ hepatomegaly, abd distention, hypoglycemia, failure to thrive, other liver-related things; subtle difference betwen them
Tx: low carb diet, give starch at night? transplant
Chart on slide 12
.
Crigler-Najjar vs. Dubin-Johnson and Rotor Syndrome
Crigler-Najjer Syndrome
- Children
- Defect in conjugation (glcuronyl transferease) of bilirubin
- Unconjugated hyperbilirubinemia
Dubin Johnson and Rotor Syndrome
- Defect in excretion of bilirubin
- Conjugated hyperbilirubinemia